High Risk Stocks - To Buy 2017

: Nine of the top ten performing stocks of the year were in the biotech sector. Companies like Vertex Pharmaceuticals (VRTX) (up 97%) and Dynavax Technologies (DVAX) (up 373%) succeeded based on FDA approvals and breakthrough trial data.

: A high-beta tech play that gained 109% due to a surge in demand and pricing for memory chips used in mobile devices and servers. Sector-Specific Risk Profiles high risk stocks to buy 2017

: The maker of Invisalign benefited from a near-monopoly on invisible braces, seeing a 131% increase as it expanded its training to thousands of dentists globally. : Nine of the top ten performing stocks

: Stocks like Freeport-McMoRan (FCX) and Cameco (CCJ) were considered high-risk due to volatile commodity prices. FCX, in particular, was viewed as a speculative "survival" play as it wrestled with high debt levels relative to cash flow. Sector-Specific Risk Profiles : The maker of Invisalign